Judges Scientific Regulatory News (JDG)

Judges Scientific plc

19 January 2012

Judges Scientific plc (the "Company" or "Judges Scientific" or "the Group")

Trading Statement

The Directors of Judges Scientific are pleased to update shareholders on the Group's trading performance in respect of the financial year ended 31 December 2011.

Operations were satisfactory throughout the year and good progress was recorded in sales, profitability and cash conversion. The Board expects that adjusted earnings per share for 2011 will be ahead of the consensus forecast and that the year's achievements will be reflected in the balance sheet.

The order book at 31 December 2011 represents approximately eight and a half weeks' sales; this is slightly down on last year, partly as a result of efforts to improve delivery times at two subsidiaries.

The global economic outlook remains difficult and the year ahead promises much uncertainty. Thankfully our sector has remained relatively sheltered from the general despondency, particularly in the Far East, which accounts for a significant proportion of our sales. With a solid order book, a strong balance sheet and a number of new or updated products, the Directors are confident that the Group is well equipped for 2012.

Ends

Press enquiries:

David Cicurel, CEO, Judges Scientific

Tel: 01342 323 600

Pascal Keane, Shore Capital

Tel: 020 7408 4090

Melvyn Marckus, Cardew Group

Tel: 07775 896 491